ECSP993003A - USE OF PEG - IFN -ALPHA AND RIBAVIRINE FOR THE TREATMENT OF CHRONIC HEPATITIS C - Google Patents
USE OF PEG - IFN -ALPHA AND RIBAVIRINE FOR THE TREATMENT OF CHRONIC HEPATITIS CInfo
- Publication number
- ECSP993003A ECSP993003A ECSP993003A ECSP993003A EC SP993003 A ECSP993003 A EC SP993003A EC SP993003 A ECSP993003 A EC SP993003A EC SP993003 A ECSP993003 A EC SP993003A
- Authority
- EC
- Ecuador
- Prior art keywords
- ifn
- peg
- treatment
- chronic hepatitis
- ribavirine
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona el uso de conjugados de PEG-IFN-a en asociación con Ribavirina para la fabricación de fármacos para el tratamiento de las infecciones por hepatitis C crónica. Además, la presente invención proporciona un método para tratar infecciones por hepatitis C crónica en pacientes que necesiten de tal tratamiento que comprende la administarción de una cantidad de un conjugado de PEG-IFN-a en asociación con una cantidad de Ribavirina efectiva para tratar la hepatitis C.The present invention provides the use of PEG-IFN-a conjugates in association with Ribavirin for the manufacture of drugs for the treatment of chronic hepatitis C infections. Furthermore, the present invention provides a method of treating chronic hepatitis C infections in patients in need of such treatment comprising administering an amount of a PEG-IFN-a conjugate in association with an amount of Ribavirin effective in treating hepatitis C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP993003 ECSP993003A (en) | 1999-06-08 | 1999-06-08 | USE OF PEG - IFN -ALPHA AND RIBAVIRINE FOR THE TREATMENT OF CHRONIC HEPATITIS C |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP993003 ECSP993003A (en) | 1999-06-08 | 1999-06-08 | USE OF PEG - IFN -ALPHA AND RIBAVIRINE FOR THE TREATMENT OF CHRONIC HEPATITIS C |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP993003A true ECSP993003A (en) | 2000-01-27 |
Family
ID=42043992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP993003 ECSP993003A (en) | 1999-06-08 | 1999-06-08 | USE OF PEG - IFN -ALPHA AND RIBAVIRINE FOR THE TREATMENT OF CHRONIC HEPATITIS C |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP993003A (en) |
-
1999
- 1999-06-08 EC ECSP993003 patent/ECSP993003A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5050297A1 (en) | USE OF PEG-IFN-ALFA AND RIBAVIRINE FOR THE TREATMENT OF CHRONIC HEPATITIS C | |
DE60121988D1 (en) | COMBINATION THERAPY WITH ANTIDIBLE AND ANTICONVULSIVE AGENTS | |
ATE309798T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIDIOL DERIVATIVES | |
NO20025627D0 (en) | Methods and compositions for treating hepatitis C virus | |
DK1140198T3 (en) | Use of hyaluronan in the manufacture of a drug for enhancing the efficacy of cytotoxic drugs | |
AR036321A1 (en) | METHOD AND PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF LATE APPEARANCE DYSCINESIA. | |
AR057746A1 (en) | PEG-IFN ALFA AND RIBAVIRINE FOR THE TREATMENT OF HEPATITIS B VIRUS | |
ECSP993003A (en) | USE OF PEG - IFN -ALPHA AND RIBAVIRINE FOR THE TREATMENT OF CHRONIC HEPATITIS C | |
CY1106388T1 (en) | THERAPY OF HEPATITIS C WITH THYMOSIN, INTEPHON, AND RIBAVIRIN | |
FR2839450B1 (en) | MEDICAMENT PREPARATION IN PARTICULAR FOR THE TREATMENT OF HERNIES DISCALES | |
AR027677A1 (en) | A THERAPEUTIC PHARMACEUTICAL COMPOSITION THAT INCLUDES CAMPTOTECHINE AND CYCLOFOSPHAMIDE FOR THE TREATMENT OF CANCER | |
AR013498A1 (en) | USE OF IFN-ALPHA AND AMANTADINE FOR THE TREATMENT OF CHRONIC HEPATITIS C USE OF IFN-ALPHA | |
DK1150981T3 (en) | Therapeutic necleoside compound | |
PT1313500E (en) | DALFOPRISTINE / QUINUPRISTINE ASSOCIATES WITH CEFPIROME | |
ECSP951438A (en) | Azithromycin Controlled Release Dosage Forms | |
TW200500073A (en) | Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof | |
TH58469A3 (en) | Use of Peg-IFN-alpha and ribavirin for the treatment of chronic hepatitis C | |
DK1311286T3 (en) | Treatment of hepatitis C with thymosin and pegylated interferon | |
GT199500023A (en) | DOSAGE FORMS OF CONTROLLED RELEASE AZITHROMYCIN | |
UY26735A1 (en) | METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS |